Trials / Conditions / Primary Hemophagocytic Lymphohistiocytosis
Primary Hemophagocytic Lymphohistiocytosis
4 registered clinical trials studyying Primary Hemophagocytic Lymphohistiocytosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis NCT06587191 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | — |
| Completed | A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Trea NCT05744063 | Swedish Orphan Biovitrum | Phase 4 |
| Completed | Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis NCT03312751 | Swedish Orphan Biovitrum | Phase 3 |
| Active Not Recruiting | Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults NCT03827343 | National Cancer Institute (NCI) | — |